Press Releases

WINNIPEG, Nov. 19, 2019 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH, OTC: MCUJF), a cardiovascular pharmaceutical company, will release financial results for the quarter ended September 30, 2019 on Tuesday, November 26, 2019. The third quarter financial statements will be made available

NEW YORK, Nov. 19, 2019 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Relmada Therapeutics, Inc. (NASDAQ: RLMD). If you are a shareholder of Relmada Therapeutics, Inc. and are intereste

NEW YORK, Nov. 19, 2019 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of PolarityTE, Inc. (NASDAQ: PTE). If you are a shareholder of PolarityTE, Inc. and are interested in obtaining additi

BOSTON, Nov. 19, 2019 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that Reenie McCarthy, CEO, will present at the Jefferies 2019 London Health

EXTON, Pa., Nov. 19, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today a

CAMBRIDGE, Mass., Nov. 19, 2019 /PRNewswire/ -- Torque, a clinical-stage immuno-oncology company developing Deep Primed™ T cell immunotherapy to direct immune power deep within the tumor microenvironment, announced today additional preclinical data for its lead Deep IL-15 Primed T cell, Deep IL-12 Primed T cell, and Deep TLR Primed T cell therapeutics programs. The

MILWAUKEE, Nov. 19, 2019 /PRNewswire/ -- The E.coli lawyers at national food safety law firm Pritzker Hageman, P.A. have been

INDIANAPOLIS, Nov. 19, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial guidance for 2020 on Tuesday, December 17, 2019. Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial guidance.The conference call will begin at

DUBLIN, Nov. 19, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the original Biologics License Application (BLA) for collagenase clostridium histolyticum (CCH) for the treatment of cellulite in the buttocks. The Prescription Drug User Fee Act (PDUFA), or target action dat

ALAMEDA, Calif., Nov. 19, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host an Investor Day on Tuesday, December 3, 2019 in Boston, MA at 8:30am Eastern Time.